No association of the HLA-A2 allele with Alzheimer's disease

Neuroscience Letters

Volumn 335, Issue 2, 2002, Pages 75-78

  Araria Goumidi, L ^a   Lambert, J C ^a   Cottel, D ^a   Amouyel, P ^a   Chartier Harlin, Marie Christine ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Alzheimer; Association; Genetic; Human leucocyte antigen A2; Polymorphism; Sporadic

Indexed keywords

APOENZYME; APOENZYME EPSILON4; HLA A2 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FRANCE; GENDER; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION; PRIORITY JOURNAL; RISK;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 21; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-A2 ANTIGEN; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0037176185     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01057-1     Document Type: Article

References (18)

1. Ballerini C., Nacmias B., Rombola G., Marcon G., Massacesi L., Sorbi S. HLA A2 allele is associated with age at onset of Alzheimer's disease. Ann. Neurol. 45:1999;397-400.
2. Harris J.M., Cumming A.M., Craddock N., StClair D., Lendon C.L. Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. Neurosci. Lett. 294:2000;37-40.
3. Jiang H., Burdick D., Glabe C.G., Cotman C.W., Tenner A.J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:1994;5050-5059.
4. Kehoe P., Wavrant-DeVrieze F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8:1999;237-245.
5. Lehmann D.J., Wiebusch H., Marshall S.E., Johnston C., Warden D.R., Morgan K., Schappert K., Poirier J., Xuereb J., Kalsheker N., Welsh K.I., Smith A.D. HLA class I, II & III genes in confirmed late-onset Alzheimer's disease. Neurobiol. Aging. 22:2001;71-77.
6. Marx F., Blasko I., Grubeck-Loebenstein B. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint. Arch. Immunol. Ther. Exp. (Warsz.). 47:1999;205-209.
7. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumor necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 357:2001;436-439.
8. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21:1995;195-218.
9. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:1996;425-432.
10. Payami H., Kaye J., Becker W., Norman D., Wetzsteon P. HLA-A2, or a closely linked gene, confers susceptibility to early-onset sporadic Alzheimer's disease in men. Neurology. 41:1991;1544-1548.
11. Payami H., Schellenberg G.D., Zareparsi S., Kaye J., Sexton G.J., Head M.A., Matsuyama S.S., Jarvik L.F., Miller B., McManus D.Q., Bird T.D., Katzman R., Heston L., Norman D., Small G.W. Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology. 49:1997;512-518.
12. Small G.W., Ebeling S.C., Matsuyama S.S., Heyman A., Reisner E.G., Renvoize E.B., Sulkava R. Variable association of HLA-A2 in men with early-onset Alzheimer disease. Neurobiol. Aging. 12:1991;375-377.
13. Small G.W., Matsuyama S.S. HLA-A2 as a possible marker for early-onset Alzheimer disease in men. Neurobiol. Aging. 7:1986;211-214.
14. Small G.W., Scott W.K., Komo S., Yamaoka L.H., Farrer L.A., Auerbach S.H., Saunders A.M., Roses A.D., Haines J.L., Pericak-Vance M.A. No association between the HLA-A2 allele and Alzheimer disease. Neurogenetics. 2:1999;177-182.
15. Smith M.A., Borsatto B. Down's syndrome, ageing and fragile sites. Mech. Ageing Dev. 101:1998;167-173.
16. Thomas D.B., Gail P.J., Nichollas W.W. Neurology. 57:2001;1153-1154.
17. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154:1999;927-936.
18. Zareparsi S., James D.M., Kaye J.A., Bird T.D., Schellenberg G.D., Payami H. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology. 58:2002;973-975.